中国生物制药(01177.HK)获执行董事兼主席谢其润增持174.8万股

Core Viewpoint - The article reports that Xie Qirun, the executive director and chairman of China Biologic Products Holdings (01177.HK), has increased his shareholding in the company, indicating confidence in its future performance [1] Group 1: Shareholding Increase - On March 30, 2026, Xie Qirun purchased 1.748 million shares at an average price of HKD 5.73 per share, totaling approximately HKD 10.016 million [1] - Following this transaction, Xie Qirun's total shareholding increased to 7.748 million shares, raising his ownership percentage from 0.03% to 0.04% [1]